
The Drug Patent Two-Step
Drug companies are willing to try everything to keep their valuable patents alive.
Drug companies are willing to try everything to keep their valuable patents alive.
Here are three big reasons why, according to IP columnist Tom Kulik.
Here’s What The Best Ones Are Doing Differently.
Which law firms were at the top of our patent category through Q3 2017?
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
When the underlying technology is so potentially valuable, companies will go to war on multiple fronts.
Here's what you need to know in 2017, in an easily consumable way.
Position your firm for long-term growth with better financial visibility and control. Learn how to track performance, manage spending, and plan strategically—download the full e-book now.